approach
acut
respiratori
failur
patient
chronic
obstruct
lung
diseas
copd
requir
special
understand
factor
regard
diagnosi
patient
evalu
interpret
laboratori
data
manag
inher
group
patient
although
term
copd
commonli
use
encompass
wide
varieti
patient
underli
common
denomin
limit
airflow
patient
fall
major
categori
chronic
bronchiti
asthma
emphysema
patient
manifest
overlap
syndrom
made
sever
compon
term
chronic
bronchiti
denot
clinic
syndrom
character
chronic
recurr
bronchial
hypersecret
clinic
diagnos
presenc
chronic
product
cough
caus
infect
neoplasm
cardiac
diseas
sputum
may
mucou
purul
eosinophil
charact
mechan
airflow
limit
relat
gener
hypcrtrophi
hyperplasia
mucussecret
bronchial
gland
diffus
inflamm
thicken
tracheobronchi
submucosa
secret
airway
asthma
character
increas
respons
tracheobronchi
tree
variou
stimuli
manifest
diffus
narrow
airway
revers
either
spontan
result
therapi
airflow
limit
result
combin
mucou
plug
airway
smooth
muscl
hypertrophi
constrict
goblet
cell
hyperplasia
diffus
mucos
edema
pulmonari
emphysema
defin
patholog
abnorm
enlarg
airspac
distal
termin
bronchiol
associ
destruct
alveolar
wall
airflow
limit
result
collaps
small
airway
due
loss
elast
recoil
lung
parenchyma
aid
maintain
patenc
small
bronchiol
robert
l
rosel
diagnosi
acut
respiratori
failur
patient
copd
requir
modif
criteria
usual
appli
patient
acutc
respiratori
failur
commonli
use
criteria
arteri
less
ton
andor
arteri
pco
greater
ton
qualif
elev
must
associ
ph
less
import
distinguish
patient
chronic
elev
paco
z
level
compens
patient
copd
chronic
function
compens
hypoxemia
andor
hypcrcarbia
import
add
standard
blood
ga
criteria
qualifi
clinic
statu
patient
rapidli
deterior
bone
cowork
defin
acut
respiratori
failur
group
patient
sole
basi
clinic
deterior
steadi
state
symptom
hour
day
prior
present
indic
endotrach
intub
mechan
ventil
use
studi
pure
clinic
base
patient
becam
stupor
unabl
cooper
therapi
arbitrari
blood
ga
criteria
use
criterion
prognosi
patient
copd
develop
acut
respiratori
failur
appear
chang
last
decad
recent
studi
patient
develop
acut
respiratori
failur
consequ
exacerb
chronic
bronchiti
surviv
initi
hospit
one
patient
requir
intub
ventil
support
compar
past
experi
hospit
surviv
acut
episod
need
intub
rang
improv
pictur
evid
better
understand
pathophysiolog
manag
patient
good
prognosi
surviv
episod
acut
decompens
patient
copd
develop
certain
physiolog
adapt
compens
respiratori
compromis
understand
chronic
compens
necessari
order
evalu
manag
patient
develop
episod
acut
respiratori
failur
hypoxemia
copd
patient
sever
decreas
vital
capac
decreas
time
forc
expiratori
volum
increas
airway
resist
increas
thorac
ga
volum
show
declin
arteri
valu
although
patient
increas
workload
breath
due
increas
airflow
resist
normal
oxygen
consumpt
rest
initi
abl
maintain
level
oxygen
consumpt
despit
reduc
oxyhemoglobin
satur
increas
oxygen
extract
tissu
level
appear
abl
extract
oxygen
thu
decreas
mixedven
oxygen
satur
normal
level
differ
arteri
mixedven
oxygen
content
therefor
remain
normal
eventu
howev
critic
level
mixedven
oxygen
reach
reduct
toler
risk
tissu
damag
point
bodi
compens
increas
hemoglobin
concentr
erythrocytosi
common
find
patient
longstand
hypoxemia
averag
increas
hematocrit
hemoglobin
hypoxem
patient
copd
gener
moder
ml
respect
hemoglobin
level
greater
gloo
ml
uncommon
increas
red
cell
mass
patient
develop
actual
correl
better
degre
arteri
oxygen
de
satur
either
hematocrit
hemoglobin
anoth
caus
erythrocytosi
smoke
almost
univers
group
patient
increas
level
carboxyhemoglobin
lead
decreas
level
oxyhemoglobin
satur
despit
normal
tissu
hypoxia
may
thu
contribut
stimulu
erythrocytosi
erythrocytosi
maintain
adequ
blood
oxygen
content
despit
sever
hypoxemia
oxyhemoglobin
desatur
anoth
compensatori
mechan
work
copd
patient
sever
hypoxemia
ensur
tissu
oxygen
shift
oxyhemoglobin
de
satur
curv
right
explain
increas
red
cell
levei
well
reduc
ph
increas
cardiac
output
appear
compens
mechan
hypoxemia
normal
individu
increas
cardiac
output
usual
respons
increas
tissu
oxygen
need
high
pulmonari
vascular
resist
howev
counteract
attempt
increas
cardiac
output
result
normal
low
cardiac
output
acid
base
statu
arteri
peo
ph
provid
major
clue
acut
chronic
respiratori
decompens
pure
respiratori
failur
lead
elev
reduc
ph
patient
chronic
respiratori
failur
renal
mechan
come
play
return
ph
toward
normal
copd
patient
chronic
co
retent
present
elev
serum
bicarbon
level
evid
compensatori
renal
mechan
addit
evid
renal
dysfunct
relat
chronic
hypercapnia
andor
hypoxemia
fluid
retent
manifest
peripher
edema
accompani
hypercapn
hypox
respiratori
failur
chronic
hypercapnia
increment
plasma
bicarbon
concentr
doubl
observ
compar
degre
acut
hypercapnia
hydrogen
ion
concentr
increas
nmollllmm
hg
peo
control
mechan
chronic
hypercapnia
howev
react
bicarbon
concentr
fall
short
return
extracellular
ph
normal
level
complic
interpret
acidbas
statu
fact
mani
patient
diuret
therapi
cor
pulmonal
diuret
patient
induc
chlorid
diuresi
chlorid
loss
seem
facilit
gener
bicarbon
kidney
increas
hydrogen
ion
excret
bicarbon
excess
probabl
maintain
continu
exchang
sodium
hydrogen
ion
sustain
elev
renal
bicarbon
threshold
metabol
alkalosi
result
associ
rise
ph
well
rise
due
secondari
respiratori
hypoventil
elev
paco
z
lead
reduct
pao
kcl
correct
bicarbon
excess
facilit
renal
bicarbon
loss
provid
chlorid
lower
inappropri
elev
bicarbon
threshold
provid
potassium
also
favor
exchang
sodium
potassium
rather
hydrogen
ion
renal
tubul
copd
patient
moder
hypoxernia
hypercapnea
normal
glomerular
filtrat
rate
normal
effect
renal
plasma
flow
normal
sodium
excret
abil
excret
water
load
normal
hypercapnea
level
pacoz
greater
torr
howev
relat
reduc
abil
kidney
excret
water
load
reduc
abil
excret
sodium
hypercapn
patient
normal
glomerular
filtrat
rate
decreas
effect
renal
plasma
flow
defect
water
excret
appear
relat
abnorm
vasopressin
secret
metabol
alter
sodium
excret
may
due
hypercapneicinduc
increas
renal
bicarbon
reabsorpt
andor
abnorm
renal
blood
flow
arteri
level
physiolog
extrem
affect
renal
function
arteri
torr
renal
plasma
flow
glomerular
filtrat
rate
reduc
arteri
reduc
glomerular
filtrat
rate
progress
increas
arteri
reduc
torr
point
urin
output
sodium
excret
fall
alter
occur
commonli
cardiovascular
system
cor
pulmonal
consequ
pulmonari
hypertens
brought
patient
hypoxia
hypoxemia
destruct
vascular
bed
occur
emphysema
electrocardiograph
ecg
abnorm
common
two
third
patient
show
ecg
evid
right
ventricular
hypertrophi
sign
compat
copd
right
atrial
hypertrophi
right
axi
deviat
low
voltag
twenti
per
cent
arrhythmia
detect
routin
ecg
show
arrhythmia
atrial
ventricular
holter
monitor
mechan
probabl
multifactori
hypoxemia
acidosi
electrolyt
imbal
contribut
bronchodil
therapi
also
may
contribut
whether
one
drug
class
arrhythmogen
anoth
unclear
acut
bronchoconstrict
patient
asthmat
compon
diseas
major
caus
acut
respiratori
failur
inhal
allergen
nonspecif
irrit
viral
respiratori
infect
emot
stress
trigger
bronchoconstrict
acut
retent
occur
reduc
alveolar
ventil
secondari
shallow
rapid
breath
pattern
patient
assum
respiratori
tract
infect
lead
acut
decompens
primari
infect
usual
viral
mycoplasma
pneumonia
smith
cowork
found
viral
mycoplasma
infect
associ
episod
decompens
patient
copd
rhinovirus
influenza
parainfluenza
coronavirus
significantli
associ
acut
respiratori
ill
lead
hyperproduct
secret
worsen
bronchit
well
asthmat
compon
obstruct
viral
infect
respiratori
tract
patient
copd
associ
increas
colon
potenti
infect
pathogen
bacteria
streptococcu
pneumonia
hemophilu
infiuenza
commoni
thromboembol
diseas
complic
alreadycompromis
pulmonari
vascular
bed
postmortem
examin
pulmonari
emboli
found
quarter
case
premortem
diagnosi
howev
difficult
clinic
pictur
similar
symptom
copd
ventilationperfus
lung
scan
correl
poorli
diagnosi
due
sever
pulmonari
vascular
distort
result
underli
lung
diseas
signific
emboli
caus
decompens
copd
patient
remain
unclear
incid
venou
thrombosi
would
predispos
pulmonari
emboli
vari
uncommon
copd
patient
spontan
pneumothorax
uncommon
caus
respiratori
failur
patient
review
patient
reveal
experienc
episod
mani
drug
potenti
exacerb
copd
betaadrenerg
receptor
blocker
commonli
use
today
treatment
wide
varieti
diseas
use
propranolol
copd
potenti
caus
mark
deterior
betacselect
agent
caus
fewer
problem
propranolol
still
lead
bronchoconstrict
higher
dose
predict
factor
unknown
care
observ
treatment
necessari
import
recogn
beta
blocker
appli
topic
signific
pulmonari
effect
timolol
potent
betaadrenerg
blocker
use
treatment
glaucoma
result
signific
bronchoconstrict
patient
administr
excess
level
supplement
oxygen
may
lead
depress
ventilatori
drive
remov
hypox
stimulu
patient
respiratori
center
blunt
sensiv
co
morphin
barbitur
also
potenti
depress
minut
volum
effect
alveolar
ventil
lead
respiratori
acidosi
parenter
nutrit
high
carbohydr
load
result
acut
respiratori
failur
total
peripher
nutrit
lead
increas
product
patient
copd
rel
fix
ventilatori
respons
hypercapnia
may
result
subsequ
respiratori
acidosi
initi
evalu
patient
includ
histori
focus
patient
baselin
cardiopulmonari
statu
well
potenti
caus
respiratori
decompens
physic
examin
focu
pulmonari
abnorm
cardiac
respons
laboratori
evalu
includ
chest
radiograph
arteri
blood
gase
complet
blood
count
provid
inform
presenc
infect
level
hemoglobin
give
indic
chronic
hypoxemia
serum
electrolyt
conjunct
arteri
ph
pco
provid
assess
patient
acidbas
statu
whether
metabol
abnorm
complic
respiratori
decompens
examin
sputum
carri
clinician
sputumwet
prepar
examin
look
eosinophil
charcotleyden
crystal
give
impress
asthmat
compon
activ
patient
diseas
gram
stain
look
predomin
organ
aid
evalu
treatment
bronchodil
therapi
mainstay
treatment
patient
theophyllin
prepar
valu
patient
known
asthmat
compon
addit
shown
improv
airflow
obstruct
patient
without
classic
find
asthma
allergi
eaton
abl
improv
fev
l
latter
group
patient
use
theophyllin
addit
bronchodil
effect
theophyllin
benefit
patient
augment
ventilatori
respons
hypoxia
although
appear
affect
hypercarb
drive
aminophyllin
also
increas
respiratori
muscl
increas
right
left
ventricular
eject
fraction
aminophyllin
use
mainten
infus
rate
mgkgh
shown
smoker
higher
drug
clearanc
requir
mgkgh
patient
pneumonia
congest
heart
failur
lower
clearanc
requir
dose
low
mgkgh
aminophyllin
clearanc
vari
markedli
critic
ill
patient
howev
serum
level
monitor
everi
hour
stabl
everi
hour
thereaft
appropri
dosag
chang
made
maintain
serum
concentr
mgl
effect
lower
level
associ
greater
improv
pulmonari
function
shorter
durat
need
intraven
iv
medic
kept
mind
iv
aminophyllin
may
make
differ
patient
minor
asthmat
compon
diseas
alreadi
oral
prepar
addit
sinc
patient
often
oral
prepar
usual
load
dose
mgkg
aminophyllin
may
necessari
fact
lead
toxic
betaadrenerg
drug
use
combin
theophyllin
sinc
mode
action
may
complement
beta
agonist
directli
stimul
product
bronchial
smooth
muscl
cyclic
amp
theophyllin
inhibit
phosphodiesteras
block
breakdown
cyclic
amp
lead
smooth
muscl
relax
bronchodil
beta
agonist
given
oral
parenter
inhal
terbutalin
isoetharin
metaproterenol
albuterol
prepar
avail
administr
one
rout
choic
rout
depend
clinic
situat
oral
parcnter
administr
theoret
effect
larg
small
airway
drawback
potenti
system
side
effect
inhal
medic
work
primarili
larger
airway
level
disadvantag
patient
bronchospasm
may
actual
induc
deep
inspir
meter
dose
inhal
critic
ill
patient
nebul
use
reduc
potenti
paradox
bronchospasm
addit
pulmonari
effect
drug
terbutalin
also
posit
cardiovascular
effect
improv
right
left
ventricular
perform
recent
year
resurg
interest
use
anticholinerg
drug
atropin
methonitr
ipratropium
bromid
manag
obstruct
lung
diseas
mechan
action
drug
appear
block
normal
baselin
cholinerg
tone
bronchial
smooth
muscl
thu
result
bronchodil
respons
anticholinerg
drug
appear
greatest
chronic
bronchiti
emphysema
oppos
classic
atop
asthma
former
group
patient
bronchodil
respons
greater
betaagonist
drug
appropri
dosag
atropin
methonitr
mgkg
nebul
corticosteroid
play
role
manag
compromis
copd
patient
mechan
action
unclear
howev
benefici
effect
asthmat
compon
diseas
well
known
patient
atop
histori
revers
obstruct
follow
bronchodil
blood
sputum
eosinophilia
like
respond
data
conflict
efficaci
patient
primarili
emphysema
bronchiti
patient
without
definit
asthma
steroid
tri
howev
definit
endpoint
must
set
determin
respons
oral
dose
rang
mgd
appropri
initi
acut
flare
iv
dosag
rang
mkg
everi
hour
methylprednisolon
equival
dose
hydrocortison
evid
therapi
higher
dose
corticosteroid
benefit
group
patient
hypoxemia
treat
supplement
oxygen
improv
tissu
oxygen
well
reliev
hypoxicinduc
pulmonari
hypertens
potenti
suppress
ventil
discuss
import
administ
oxygen
control
fashion
use
venturityp
mask
deliv
inspir
fraction
oxygen
deliv
oxygen
nasal
cannula
provid
flow
adequ
quantifi
breath
pattern
critic
ill
patient
rapid
shallow
respir
fraction
oxygen
deliv
patient
llmin
nasal
cannula
may
actual
equival
greater
might
prove
excess
unknown
patient
ventilatori
drive
suppress
supplement
oxygen
close
clinic
observ
requir
use
oxygen
tensioncarbon
dioxid
tension
diagram
bone
cowork
suggest
sever
hypoxemia
acidosi
initi
discriminatori
retent
baselin
hypercarbia
increas
secret
treat
aggress
eosinophil
sputum
respond
well
corticosteroid
purul
secret
manag
bronchial
hygien
techniqu
chest
physic
therapi
use
antibiot
set
controversi
sinc
usual
infecti
etiolog
acut
bronchiti
viral
theoret
would
matter
antibiot
direct
bacteria
use
studi
found
benefit
despit
data
clinician
would
treat
purul
bronchiti
without
evid
obviou
pneumonia
broad
spectrum
antibiot
ampicillin
cephalosporin
patient
hypochlorem
alkalosi
secondari
diuret
therapi
correct
reduc
compon
hypoventil
respons
metabol
abnorm
treatment
choic
kcl
supplement
import
realiz
group
patient
one
treat
hypochloremia
concern
patient
potassium
level
patient
normokalem
kidney
spill
excess
potassium
given
patient
potassium
prepar
includ
chlorid
obvious
valu
treat
problem
acetazolamid
carbon
anhydras
inhibitor
advoc
way
correct
metabol
alkalosi
patient
primari
problem
howev
hypochlorem
alkalosi
drug
therefor
use
tempor
adjunct
chlorid
replac
respiratori
stimul
effect
group
patient
acetazolamid
advoc
past
realli
caus
sustain
improv
copd
patient
medroxyprogesteron
acet
dose
mg
tid
shown
mild
respiratori
stimul
awak
copd
patient
howev
evid
benefici
acut
decompens
aminophyllin
augment
ventilatori
respons
use
patient
bronchodil
effect
doxapram
hcl
effect
central
stimul
ventil
use
manag
copd
patient
unless
patient
ventilatori
failur
due
sed
excess
oxygen
use
doxapram
type
patient
recommend
patient
respiratori
rate
less
doxapram
may
temporarili
aid
manag
copd
patient
acut
decompens
drive
breath
maintain
patient
physic
unabl
maintain
adequ
alveolar
ventil
ad
doxapram
situat
may
increas
patient
sens
dyspnea
psycholog
discomfort
without
improv
ventil
drug
manipul
pulmonari
hypertens
complic
clinic
pictur
patient
recent
undergo
great
deal
research
oxygen
remain
drug
choic
drug
nitroprussid
nitroglycerin
hydralazin
nifedipin
use
conflict
result
rational
use
drug
decompens
copd
patient
would
revers
cor
pulmonal
develop
vasodil
might
directli
reliev
pulmonari
hypertens
improv
cardiac
function
caus
afterload
reduct
although
drug
potenti
reduc
pulmonari
hypertens
improv
right
ventricular
function
also
reduc
preload
worsen
right
ventricular
function
addit
potenti
worsen
ventilationperfus
relationship
lung
caus
worsen
ga
exchang
present
time
drug
consid
standard
mode
therapi
copd
patient
acut
decompens
patient
hematocrit
greater
phlebotomi
may
occasion
benefit
central
nervou
system
find
accompani
evid
sludg
retin
blood
vessel
would
indic
phlebotomi
right
ventricular
function
also
improv
decis
phlebotom
howev
weigh
reduct
oxygencarri
capac
patient
develop
ventilatori
failur
fall
ph
rise
despit
aggress
medic
manag
manag
ventil
consid
respiratori
failur
result
obvious
revers
process
decis
easi
patient
intub
caus
failur
gradual
deterior
patient
underli
lung
diseas
decis
intub
difficult
take
account
ethic
well
medic
issu
basic
ventilatori
manag
well
describ
elsewher
sever
featur
ventil
manag
uniqu
group
patient
minut
volum
patient
receiv
adjust
maintain
ph
one
strive
normal
tend
reduc
metabol
compens
kidney
acidbas
statu
patient
reequilibr
paco
lower
patient
maintain
wean
much
difficult
supplement
oxygen
titrat
maintain
adequ
pao
level
least
torr
much
ventilatori
drive
suppress
flow
rate
machin
adjust
assur
adequ
expiratori
phase
expir
breath
incomplet
phenomenon
known
dynam
hyperinfl
occur
ga
remain
chest
end
tidal
volum
breath
gradual
increas
lead
increas
function
residu
volum
disadvantag
patient
ventil
take
place
lessthanoptim
point
normal
complianc
curv
work
breath
increas
group
patient
howev
may
actual
requir
small
amount
resist
expir
maintain
patenc
time
spent
ventil
kept
short
possibl
ventil
use
help
patient
acut
episod
prolong
time
ventil
lead
problem
muscular
dyscoordin
risk
barotrauma
infect
alter
normal
acidbas
equilibrium
gener
declin
overal
statu
patient
readi
aggress
effort
made
wean
patient
slow
wean
prolong
time
ventil
lead
complic
patient
copd
develop
acut
respiratori
failur
requir
special
attent
manag
patient
sever
copd
often
cor
pulmonal
complex
acidbas
compens
alter
respi
